I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Mesa, RA
21
results:
Search for persons
X
Format
Online (21)
Mediatypes
Articles (Online) (3)
OpenAccess-fulltext (18)
Languages
english (18)
spanish (1)
Sorted by: Relevance
Sorted by: Year
?
1
Diastolic Blood Pressure and Cognitive Functioning: Differe..:
Mathew, A
;
Mesa, RA
;
Nahodyl, L
...
American Journal of Alzheimer's Disease & Other Dementias®. 38 (2023) - p. 153331752311722 , 2023
Link:
https://doi.org/10.1177/..
?
2
TRANSLATION AND LINGUISTIC VALIDATION OF THE MODIFIED MYELO..:
Eremenco, S
;
Oko-osi, H
;
Arnold, B
...
Value in Health. 18 (2015) 7 - p. A471-A472 , 2015
Link:
https://doi.org/10.1016/..
?
3
Symptomatic benefit of momelotinib in patients with myelofi..:
Mesa, RA
;
Hudgens, S
;
Floden, L
...
doi:10.1002/cam4.5799. , 2024
Link:
https://doi.org/10.1002/..
?
4
Ruxolitinib versus best available therapy for polycythemia ..:
Harrison, CN
;
Nangalia, J
;
Boucher, R
...
doi:10.1200/JCO.22.01935. , 2024
Link:
https://doi.org/10.1200/..
?
5
Ruxolitinib Versus Best Available Therapy for Polycythemia ..:
Harrison, CN
;
Nangalia, J
;
Boucher, R
...
Journal of Clinical Oncology, 2023, pp. JCO2201935 -. , 2023
Link:
https://repository.icr.a..
?
6
Diastolic blood pressure and cognitive functioning: differe..:
Mathew, A
;
Mesa, RA
;
Nahodyl, L
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398835/. , 2023
Link:
http://www.ncbi.nlm.nih...
?
7
MOMENTUM: momelotinib vs danazol in patients with myelofibr..:
Verstovsek, S
;
Chen, C-C
;
Egyed, M
...
doi:10.2217/fon-2020-1048. , 2021
Link:
https://doi.org/10.2217/..
?
8
Association of clinical factors and recent anticancer thera..:
Grivas, P
;
Khaki, AR
;
Wise-Draper, TM
...
qt49m429m0. , 2021
Link:
https://escholarship.org..
?
9
A phase 2 study of momelotinib, a potent JAK1 and JAK2 inhi..:
Verstovsek, S
;
Courby, S
;
Griesshammer, M
...
issn:0145-2126. , 2017
Link:
http://hdl.handle.net/11..
?
10
Profile of pomalidomide and its potential in the treatment ..:
Gowin KL
;
Mesa RA
http://www.dovepress.com/profile-of-pomalidomide-and-its-potential-in-the-treatment-of-myelofib-peer-reviewed-article-TCRM. , 2015
Link:
https://doaj.org/article..
?
11
Management of cytopenias in patients with myelofibrosis tre..:
Verstovsek S
;
Gotlib J
;
Gupta V
...
http://www.dovepress.com/management-of-cytopenias-in-patients-with-myelofibrosis-treated-with-r-a15309. , 2013
Link:
https://doaj.org/article..
?
12
Ruxolitinib as an emerging treatment in myelofibrosis:
Emanuel RM
;
Geyer HL
;
Mesa RA
http://www.dovepress.com/ruxolitinib-as-an-emerging-treatment-in-myelofibrosis-a12419. , 2013
Link:
https://doaj.org/article..
?
13
Recent developments in myelofibrosis:
Mesa RA
;
Bogenberger JM
;
Tibes R
http://www.dovepress.com/recent-developments-in-myelofibrosis-a10273. , 2012
Link:
https://doaj.org/article..
?
14
5-Azacitidine has limited therapeutic activity in myelofibr..:
Mesa, RA
;
Verstovsek, S
;
Rivera, C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721528/. , 2008
Link:
http://www.ncbi.nlm.nih...
?
15
Bortezomib therapy in myelofibrosis: a phase II clinical tr..:
Mesa, RA
;
Verstovsek, S
;
Rivera, C
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167436/. , 2008
Link:
http://www.ncbi.nlm.nih...
1-15